NASDAQ · Medical - Devices

InMode Ltd. (INMD) Stock

$14.21 +0.92% NASDAQ: INMD Healthcare

Valuation

MetricValue
Price$14.21
Market Cap$816.80M
P/E Ratio11.27
P/B Ratio1.32
P/S Ratio2.16
EPS (TTM)$1.43
52-Week High$16.74
52-Week Low$12.72
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE11.80%
ROA10.76%
ROCE10.80%
Gross Margin22.97%
Operating Margin22.97%
Net Margin20.69%
Debt/Equity0.01
Current Ratio9.85

Annual Financials (USD)

Metric20212022202320242025
Revenue$358.0M$454.0M$492.0M$395.0M$370.0M
Operating Profit$167.0M$198.0M$196.0M$113.0M$85.0M
Net Profit$165.0M$162.0M$198.0M$181.0M$94.0M
EPS$1.92$1.89$2.30$2.25$1.43
Op Margin46.8%43.5%39.8%28.5%23.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$479.0M$644.0M$863.0M$786.0M$766.0M
Total Liabilities$63.0M$90.0M$76.0M$82.0M$83.0M
Cash$68.0M$98.0M$144.0M$155.0M$303.0M
Borrowings$5.0M$5.0M$9.0M$8.0M$13.0M

Latest News

Sector Update: Health Care Stocks Lower Early Monday MT Newswires · Jul 13, 2026 Sector Update: Healthcare MT Newswires · Jul 13, 2026 Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Renewed US-Iran Conflict Lifts Oil Prices MT Newswires · Jul 13, 2026 InMode Reports Preliminary Q2 Revenue MT Newswires · Jul 13, 2026 InMode to Report Second Quarter 2026 Financial Results on August 5, 2026, Expects Q2 Revenue Between $95.2M-$95.4M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M PR Newswire · Jul 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$175.0M$182.0M$177.0M$133.0M$85.0M
Investing Cash Flow$-161.0M$-111.0M$-137.0M$162.0M$185.0M
Financing Cash Flow$-35.0M$-41.0M$0$-283.0M$-127.0M
Net Cash Flow$-1.0M$29.0M$47.0M$11.0M$147.0M
Free Cash Flow$174.0M$180.0M$176.0M$132.0M$84.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.23
EV / EBITDA4.97
FCF Yield10.80%
Quick Ratio7.28
Interest Coverage0.00
Return 1Y1.07%
Return 3Y-66.19%
Return 5Y-70.88%

Ownership

Insiders Held13.14%
Institutions Held59.23%
Institutions Float Held68.19%
Institutional HolderSharesReport Date
Doma Perpetual Capital Management LLC3,067,4312026-03-31
Acadian Asset Management. LLC2,593,2032026-03-31
Renaissance Technologies, LLC2,586,2182026-03-31
Blackrock Inc.2,254,7292026-03-31
Menora Mivtachim Holdings Ltd.2,040,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About InMode Ltd.

InMode Ltd. is led by CEO Moshe Mizrahy, publicly traded since 2019.

InMode Ltd. (INMD) stock trades at $14.21 with a market capitalization of $816.80M. The stock is valued at a price-to-earnings (P/E) ratio of 11.27, price-to-book of 1.32, price-to-sales of 2.16. Over the past 52 weeks the stock has ranged between $12.72 and $16.74, and currently trades 15.1% below its 52-week high.

On profitability, InMode Ltd. generates a return on equity (ROE) of 11.80%, return on capital employed of 10.80%, an operating margin of 22.97%, a net profit margin of 20.69%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides